Low prevalence of p-ANCA in unaffected relatives of patients with ulcerative colitis from a mediterranean area

Inflammatory Bowel Diseases

Volumn 2, Issue 1, 1996, Pages 11-15

  Monteleone, Giovanni ^a   Marasco, Raffaella ^a   Parrello, Tiziana ^a   De Medici, Antonio ^b   Giglio, Andrea ^b   Doldo, Patrizia ^a   Luzza, Francesco ^a   Pallone, Francesco ^a,c  

^a UNIVERSITY MEDITERRANEA OF REGGIO CALABRIA   (Italy)

^b Ospedale Ciaccio   (Italy)

^c Policlinico Universitario   (Italy)

Author keywords

Antineutrophil antibodies (ANCA); Crohn's disease; Genetic markers; Ulcerative colitis

Indexed keywords

EID: 0010370586     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/00054725-199603000-00003     Document Type: Article

References (25)

1. Satsangi J, Jewell DP, Rosenberg WMC, Bell JI. Genetics of inflammatory bowel disease. Gut 1994;35:696-700.
2. Yang H, Shohat T, Rotter JI. The genetics of inflammatory bowel disease. In: MacDermott RP, Stenson WF, eds. Inflammatory bowel disease. New York: Elsevier Science Publishing, 1992:17-51.
3. Toyoda H, Wang SJ, Yang H, Redford A, Magalong D, Tyan D, McElree C, Pressman S, Shanahan F, Targan S, Rotter JI. Distinct associations of HLA class II genes with inflammatory bowel disease. Gastroenterology 1993;104:741-8.
4. Korsmeyer SJ, Williams RC Jr, Wilson ID, Strickkland RG. Lymphocytotoxic antibody in inflammatory bowel disease: a family study. N Engl J Med 1975;293:1117-20.
5. Fiocchi C, Roche JK, Michener WM. High prevalence of antibodies to intestinal epithelial antigens in patients with inflammatory bowel disease and their relatives. Ann Intern Med 1989;110:786-94.
6. Jeanette JC, Wilkman AS, Falk RJ. Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis. Am J Pathol 1989;135:921-30.
7. Gross WL, Schmitt WH, Csernok E. ANCA and associated diseases: immunodiagnostic and pathogenetic aspects. Clin Exp Immunol 1993;91:1-12.
8. Jennette JC, Hoidal JH, Falk RJ. Specificity on antineutrophil cytoplasmic autoantibodies for proteinase 3. Blood 1990;78:2263-4.
9. Falk RJ, Jennette JC. Antineutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 1988;318:1651-7.
10. Saxon A, Shanahan F, Landers C, Ganz T, Targan S. A subset of antineutrophil anticytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol 1990;86:202-10.
11. Duerr RH, Targan SR, Landers LJ, Sutherland LR, Shanahan F. Antineutrophil cytoplasmic antibodies in ulcerative colitis: comparison with other colitides/diarrheal illnesses. Gastroenterology 1991;100:1590-6.
12. Oudkerk Pool M, Ellerbroek PM, Ridwan BU, Goldscheneding R, von Blomberg BME, Pena AS, Dolman KM, Bril H, Dekker W, Nauta JJ, Gans ROB, Breed H, Meuwissen SGM. Serum antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease are mainly associated with ulcerative colitis: a correlation study between perinuclear antineutrophil cytoplasmic autoantibodies and clinical parameters, medical and surgical treatment. Gut 1993;34:46-50.
13. Yang H, Rotter JI, Toyoda H, Landers C, Tyan D, McElree CK, Targan SR. Ulcerative colitis: a genetically heterogenous disorder defined by genetic (HLA class II) and subclinical (antineutrophil cytoplasmic antibodies) markers. J Clin Invest 1993;92:1080-4.
14. Shanahan F, Duerr RH, Rotter JI, Yang H, Sutherland LR, McElree C, Landers CJ, Targan SR. Neutrophil autoantibodies in ulcerative colitis: familial aggregation and genetic heterogeneity. Gastroenterology 1992;103:456-61.
15. Reumaux D, Delecourt L, Colombel JF, Noel LH, Duthilleul P, Cortot A. Antineutrophil cytoplasmic autoantibodies in relatives of patients with ulcerative colitis. Gastroenterology 1992;103:1706.
16. Lee JCW, Lennard-Jones JE, Cambridge G. Antineutrophil antibodies in familial inflammatory bowel disease. Gastroenterology 1995;108:428-33.
17. Truelove SC, Witts LJ. Cortisone in ulcerative colitis: final report of a therapeutic trial. Br Med J 1955;2:1041-8.
18. Thompson WG, Dotevall G, Drossman DA, Heaton KW, Kruis W. Irritable bowel syndrome: guidelines for the diagnosis. Gastroenterol Int 1989;2:92-5.
19. Boyum A. Separation of leukocytes from blood and bone marrow. Scand J Clin Lab Invest 1968;21:31-50.
20. Wiik A. Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. APMIS 1988;97 (suppl 6):12-3.
21. Casanova MG, Oudkerk Pool M, Pena AS, Crusius JBA, Fonk JCM, Schieveld S, Bouma G, von Blomberg BME, Meuwissen SGM, Giphart MJ. A subgroup of ulcerative colitis (UC) defined with genetic (HLA-DR) and immunological (p-ANCA) markers. Gastroenterology 1993;104: A709.
22. Seibold F, Slametschka D, Gregor M, Weber P. Neutrophil autoantibodies: a genetic marker in primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1994;107: 532-6.
23. Reumaux D, Colombel J-F, Delecourt L, Noel L-H, Cortot A, Duthilleul P. Anti-neutrophil cytoplasmic auto-antibodies (ANCA) in patients with ulcerative colitis (UC): influence of disease activity and familial study. Adv Exp Med Biol 1993; 336:515-8.
24. Mehal WZ, Lo SK, Wordsworth PB, Chapman RW, Fleming KA. HLA Drw52a and Dw2 are not associated with the development of antineutrophil antibody type 1 (ANCA 1) in ulcerative colitis (UC). Gastroenterology 1993;104:A745.
25. Vecchi M, Bianchi MB, Sinico RA, Radice A, Meucci G, Torgano G, Omodei P, Forzenigo L, Landoni M, Arrigoni M, Pozzi C, De Franchis R. Antibodies to neutrophil cytoplasm in Italian patients with ulcerative colitis: sensitivity, specificity and recognition of putative antigens. Digestion 1994;55:34-9.